BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eroglu Y, Byrne WJ. Hepatic encephalopathy. Emerg Med Clin North Am 2009;27:401-14. [PMID: 19646644 DOI: 10.1016/j.emc.2009.04.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Ramírez-polo A, Márquez-guillén E, González-aguirre AJ, Casanova-sánchez IE, Chávez-ruiz R, Carrillo-maravilla E, López-méndez E. Persistent hepatic encephalopathy secondary to portosystemic shunt occluded with Amplatzer device. Annals of Hepatology 2014;13:456-60. [DOI: 10.1016/s1665-2681(19)30854-3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Xu J, Ma R, Chen LF, Zhao LJ, Chen K, Zhang RB. Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials. Hepatobiliary Pancreat Dis Int 2014;13:354-60. [PMID: 25100119 DOI: 10.1016/s1499-3872(14)60280-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
3 Rivera-Espinosa L, Floriano-Sánchez E, Pedraza-Chaverrí J, Coballase-Urrutia E, Sampieri AI, Ortega-Cuellar D, Cárdenas-Rodríguez N, Carmona-Aparicio L. Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy. Int J Mol Sci 2013;14:16184-206. [PMID: 23921686 DOI: 10.3390/ijms140816184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Casaletto JJ. Is salt, vitamin, or endocrinopathy causing this encephalopathy? A review of endocrine and metabolic causes of altered level of consciousness. Emerg Med Clin North Am 2010;28:633-62. [PMID: 20709247 DOI: 10.1016/j.emc.2010.03.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Pitzele HZ, Tolia VM. Twenty per hour: altered mental state due to ethanol abuse and withdrawal. Emerg Med Clin North Am 2010;28:683-705. [PMID: 20709249 DOI: 10.1016/j.emc.2010.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Buob S, Johnston AN, Webster CR. Portal hypertension: pathophysiology, diagnosis, and treatment. J Vet Intern Med. 2011;25:169-186. [PMID: 21382073 DOI: 10.1111/j.1939-1676.2011.00691.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
7 Toris GT, Bikis CN, Tsourouflis GS, Theocharis SE. Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit 2011;17:RA53-63. [PMID: 21278704 DOI: 10.12659/msm.881387] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
8 Ashraf A, Clark M, So PW. The Aging of Iron Man. Front Aging Neurosci 2018;10:65. [PMID: 29593525 DOI: 10.3389/fnagi.2018.00065] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 17.5] [Reference Citation Analysis]
9 Brader RA, Kim KR. Transhepatic embolization of a congenital intrahepatic portosystemic shunt for the treatment of hepatic encephalopathy in a noncirrhotic patient using Amplatzer vascular plug device. Radiol Case Rep 2017;12:318-22. [PMID: 28491179 DOI: 10.1016/j.radcr.2016.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Hansen L, Sasaki A, Zucker B. End-Stage Liver Disease: Challenges and Practice Implications. Nursing Clinics of North America 2010;45:411-26. [DOI: 10.1016/j.cnur.2010.03.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
11 Johnstone D, Milward EA. Molecular genetic approaches to understanding the roles and regulation of iron in brain health and disease. J Neurochem 2010;113:1387-402. [PMID: 20345752 DOI: 10.1111/j.1471-4159.2010.06697.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
12 Josefsen K, Nielsen SM, Campos A, Seifert T, Hasholt L, Nielsen JE, Nørremølle A, Skotte NH, Secher NH, Quistorff B. Reduced gluconeogenesis and lactate clearance in Huntington's disease. Neurobiology of Disease 2010;40:656-62. [DOI: 10.1016/j.nbd.2010.08.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
13 Dunkel B, Chaney KP, Dallap-Schaer BL, Pellegrini-Masini A, Mair TS, Boston R. Putative intestinal hyperammonaemia in horses: 36 cases. Equine Vet J 2011;43:133-40. [PMID: 21592205 DOI: 10.1111/j.2042-3306.2010.00128.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
14 Mittal P, Gupta R, Mittal G, Kalia V. Association between portal vein color Doppler findings and the severity of disease in cirrhotic patients with portal hypertension. Iran J Radiol 2011;8:211-7. [PMID: 23329943 DOI: 10.5812/iranjradiol.4489] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
15 Tan W, Steadman RH, Farmer DG, Hong JC, Busuttil RW, Apinyachon W, Xia VW. Pretransplant Neurological Presentation and Severe Posttransplant Brain Injury in Patients With Acute Liver Failure. Transplantation 2012;94:768-74. [DOI: 10.1097/tp.0b013e3182620596] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lunia MK, Sharma BC, Sharma P, Sachdeva S, Srivastava S. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial. Clin Gastroenterol Hepatol 2014; 12: 1003-8. e1. [PMID: 24246768 DOI: 10.1016/j.cgh.2013.11.006] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 10.7] [Reference Citation Analysis]
17 Tsai CY, Su CH, Chan JY, Chan SH. Nitrosative Stress-Induced Disruption of Baroreflex Neural Circuits in a Rat Model of Hepatic Encephalopathy: A DTI Study. Sci Rep 2017;7:40111. [PMID: 28079146 DOI: 10.1038/srep40111] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
18 Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A. Pharmacotherapy for Hepatic Encephalopathy: . Drugs 2010;70:1131-48. [DOI: 10.2165/10898630-000000000-00000] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
19 Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. [PMID: 26041963 DOI: 10.1016/j.jceh.2014.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]